Dr. Philip Trillmich

Representative experience includes advising:

Technology, telecommunications and media

DNEG subscription by Al Saqer Group, 2024
2024, DNEG SARL, a leading visual effects service provider, on the intellectual property aspects of a USD 100M subscription by Al Saqer Group.

Monese/XYP separation, 2024
Pan-European fintech Monese and its global platform as a service (PaaS) business XYB in the separation from their existing group structure to become two independent businesses.

Gambling.com Group's acquisition of Freebets.com, 2024
Gambling.com Group, a leading provider of digital marketing services for the global online gambling industry, on the intellectual property aspects of its US$42.5m acquisition of Freebets.com and related assets from AIM-listed XLMedia plc.

Acquisition of The Spectator, 2024
Sir Paul Marshall and Old Queen Street Ventures Limited on the intellectual property aspects of their acquisition of The Spectator magazine.

NaMa Capital's acquisition of a stake in DNEG, 2023
NaMa Capital Limited, a global investment firm, on the intellectual property aspects of its acquisition of a stake in DNEG, one of the world's leading visual effects studios for feature film and television.

Nordic Capital's sale of Macrobond, 2023
Nordic Capital on the intellectual property aspects of the sale of Macrobond, a leading, global provider of software and macroeconomic and financial data, to Francisco Partner

The Carlyle Group's its acquisition of Tescan Orsay, 2023
The Carlyle Group on the intellectual property aspects of its acquisition of Tescan Orsay Holding, a leading manufacturer of electron microscopes and other high-tech scientific instruments.

Jio's investment in Glance, 2022
Jio Platforms Limited, a subsidiary of Reliance Industries Limited that has built an all-IP data and future-proof network with the latest 4G LTE technology, on the intellectual property aspects of its US$200 million investment in Glance Pte. Ltd., a leading AI-driven software for displaying lock screen content for mobile devices primarily in India.

Regnology's acquisitions of K-Helix and PwC Tax Information Reporting, 2022
Regnology Group GmbH, a portfolio company of Nordic Capital, on the intellectual property aspects of:

• its bolt-on acquisition of the K-Helix software and business from KPMG LLP; and
• its acquisition of PwC Tax Information Reporting Limited, a provider of tax reporting software solutions, from PwC Holdings (UK) Limited.

Kobalt Music's record music operations divestment, 2021
Kobalt Music Group Limited on the intellectual property aspects of the divestment of its recorded music operations to Sony Music Entertainment.

International Game Technology's sale of Lottomatica, 2020
International Game Technology PLC on the intellectual property aspects of the €950 million sale of its Italian B2C gaming business to Gamenet Group S.p.A.

Life sciences and healthcare

XSpectra Medical Devices' acquisition of XL Precision Technologies, 2024
Spectra Medical Devices LLC, a portfolio company of QHP Capital, on the intellectual property aspects of its acquisition of XL Precision Technologies, a contract development and manufacturing organization for the medical device industry.

Takeda's product divestments, 2024
Takeda Pharmaceutical Company Limited on the intellectual property and commercial contracts aspects of its divestments of:

• pharmaceutical products to Hikma Pharmaceuticals PLC in select territories in the Middle East and North Africa region; and
• an oncological product to Esteve Pharmaceutical S.A.

Karo Healthcare, acquisition of Lamisil, 2023
Karo Healthcare, a consumer healthcare company (and EQT portfolio company), on the intellectual property and commercial contracts aspects of its £235 million acquisition of the over-the-counter skin healthcare brand Lamisil from Haleon UK Holdings Ltd.

Clinigen's divestments, 2023
Clinigen, a global pharmaceuticals services and products company (and Triton portfolio company) on the intellectual property and commercial contracts aspects of:

• the £167 million sale of Proleukin to Iovance Biotherapeutics;
• the sale of Lamda Laboratories, a contract development business, to Adragos; and
• the sale of a portfolio of cancer supportive care products to CNX Therapeutics.

Carlyle's acquisition of Meopta, 2023
The Carlyle Group on the intellectual property and commercial contracts aspects of its acquisition of Meopta Optika, a manufacturer of optical, opto-mechanical, and opto-electronic solutions headquartered in the Czech Republic

Nordic Capital's acquisition of CARE Fertility, 2022
Nordic Capital on the intellectual property aspects of its acquisition of CARE Fertility from Silverfleet Capital.

FutureLife's acquisition of London IVF clinic, 2022
FutureLife a.s., a pan-European provider of IVF and related services, on the intellectual property aspects of its acquisition of London IVF clinic The Centre for Reproductive and Genetic Health. 

Triton's takeover of Clinigen, 2021
Triton Partners on the intellectual property aspects of its £1.2 billion recommended takeover of Clinigen Group plc, an AIM-listed global pharmaceutical services and products company.

Karo Pharma's acquisition of Sylphar, 2021
Karo Pharma, a consumer healthcare company (and EQT portfolio company), on the intellectual property and commercial contracts aspects of its €300 million acquisition of Sylphar, a Belgium-based over-the-counter products manufacturer, from private equity firm Vendis Capital and Sylphar's founder.

Medcaptain Medical Technology's acquisition of Penlon, 2021
Medcaptain Medical Technology on the intellectual property aspects of its acquisition of the UK-based medical device company Penlon from BTL Medical Technology.

Angelini's acquisition of ThermaCare, 2020
Italian pharma and consumer healthcare group Angelini on the intellectual property and commercial contracts aspects of its worldwide acquisition, outside North America, of the ThermaCare business from GlaxoSmithKline.

CVC's acquisition of The Assisted Conception Unit Limited, 2020
CVC on on the intellectual property aspects its acquisition of The Assisted Conception Unit Limited, a London based clinic providing a full range of reproductive investigation and fertility treatments as well as genetic services.

Takeda's product divestments, 2019-2020
Takeda Pharmaceutical Company Limited on the intellectual property and commercial contracts aspects of its divestments of select OTC and prescription pharmaceutical products in seven transactions, comprising:

• the US$322 million divestment to Hasten Biopharmaceutic Co. Ltd. In China
• the US$562 million divestment to Cheplapharm in Europe and Canada;
• the US$278 million divestment to Celltrion in Asia Pacific;
• the US$670 million divestment to Orifarm in Europe;
• the US$825 million divestment to Hypera Pharma in Latin America;
• the US$660 million divestment to STADA in Russia, Georgia, and a number of CIS countries; and
• the US$200 million divestment to Acino in the NEMEA region.

Infrastructure, transportation and logistics / energy

Actis's acquisition of Telekom Srbija's towers business, 2024
Private equity firm Actis on the commercial contracts aspects of the carve-out and acquisition of Telekom Srbija's towers business, comprising approximately 1,800 macro towers across Serbia, Bosnia & Herzegovina and Montenegro.

Antin's acquisition of Portakabin, 2024
Antin Infrastructure Partners on the commercial contracts aspects of acquisition of Portakabin, a market leader in the design and provision of modular building infrastructure, from Shepherd Building Group.

North Sea Midstream Partners' acquisition of a liquefaction plant, 2024
North Sea Midstream Partners, an investee company of JP Morgan Infrastructure and Wren House Infrastructure, on the commercial contracts aspects of its acquisition of the Risavka liquefaction plant in Norway.

Morgan Stanley Infrastructures Partners' acquisition of Valoriza, 2023
Morgan Stanley Infrastructure Partners on the commercial contracts aspects of its acquisition of Valoriza Servicios Medioambientales, S.A. from Spanish construction group Sacyr S.A.

Arjun Infrastructure Partners' acquisition of a stake in Appia, 2022
Arjun Infrastructure Partners on the commercial contracts aspects of its acquisition of a 45 percent stake in Appia Group Limited, which owns and operates the Welcome Break motorway services areas in the UK.

Bluewater's acquisition of Stanley Oil & Gas, 2022
Bluewater, the global energy investment firm, on the commercial contracts aspects of its acquisition, through portfolio company Pipeline Technique, of Stanley Oil & Gas from Stanley Black & Decker, Inc.

DigitalBridge's carve-out acquisition of a data center business, 2021
DigitalBridge, an American international investment firm, on the commercial contracts aspects of its US$750 million carve-out acquisition of PCCW group's data center business in Hong Kong and Malaysia.

Consumer & retail / agriculture / food and beverage

Saudi Agricultural and Livestock Investment Company's acquisition of Olam Agri, 2024
Saudi Agricultural and Livestock Investment Company, a wholly-owned subsidiary of the Public Investment Fund on behalf of the Kingdom of Saudi Arabia, on the intellectual property aspects of its acquisition of 35.43 percent of Singapore-based commodity trader, Olam Agri Holdings, for US$1.24 billion.

Delivery Hero's sale of its foodpanda business in Taiwan, 2024
Delivery Hero on the intellectual property aspects of the US$950 million cash sale of its foodpanda business in Taiwan to Uber Technologies, Inc.

Investcorp's sale of Georg Jensen, 2023
Investcorp, a Bahrain-headquartered global manager of alternative investment products, on the the intellectual property aspects of its €155 million sale of the Danish designer company Georg Jensen to Fiskars Group.

The Carlyle Group's acquisition of Incubeta, 2023
The Carlyle Group on the intellectual property and commercial contracts aspects of its acquisition of Incubeta Holdings International Limited, a UK-based digital branding and advertising agency.

Iconix's acquisition of the PONY brand, 2022
Brand management company Iconix International Inc. on the intellectual property aspects of its acquisition of the global rights across all product categories to the PONY brand (excluding China and Taiwan), from Hong Kong-based Symphony Holdings Ltd.

Verallia's acquisition of Allied Glass, 2022
Verallia, the leading European and the world's third largest producer of glass containers for food and beverages, on the intellectual property and commercial contracts aspects of its £315 million acquisition of Allied Glass, a market leader in the UK premium glass packaging segment.

Red Sea Cruise Company's joint venture with Aman, 2021
Red Sea Cruise Company, a wholly-owned subsidiary of the Public Investment Fund on behalf of the Kingdom of Saudi Arabia, on the intellectual property aspects of its joint venture with the Aman luxury group, set-up for the purpose of launching a new super luxury cruise line in the Red Sea.

Engineering / water and wastewater / mining and metals

Lanes Group's acquisition by Global Infrastructure Partners, 2024
Lanes Group Limited, one of the UK's leading providers of water and wastewater services, and its shareholders on the intellectual property aspects of its acquisition by funds managed by Global Infrastructure Partners, a part of BlackRock.

SigmaRoc's acquisition of a lime business, 2023
SigmaRoc plc, an AIM-listed specialist quarried materials group, on the intellectual property aspects of its c.£870 million acquisition of certain European lime businesses from CRH plc, a provider of diversified building materials.

SPIE's acquisition of Correll Electrical Engineering, 2023
French listed group SPIE on the intellectual property and commercial contracts aspects of its acquisition of Correll Electrical Engineering, a group specialising in electrical engineering and cabling.

SPIE's divestment of its UK engineering business, 2022
French listed group SPIE on the intellectual property and commercial contracts aspects of the divestment of its UK engineering business to Imtech.

Oaktree Capital Management's disposal of MWH Treatment, 2021
Oaktree Capital Management on the intellectual property aspects of its disposal of MWH Treatment, the UK's leading water engineering and construction management company, to RSK.

Financial services

Oaktree Capital Management's carve-out disposal of atomos, 2021
Oaktree Capital Management on the intellectual property and commercial contracts aspects of the carve-out and acquisition of atomos, the UK private wealth management and investment businesses, from Sanlam.

Gopher Investments' acquisition of Finalto, 2021
Gopher Investments on the intellectual property aspects of its acquisition of Finalto, the fintech subsidiary business of Playtech plc, an LSE-listed, Isle of Man-incorporated FTSE 250 public company and the world's largest online gambling software provider, for US$250 million.

Tink AB's sale to Visa, 2021
The shareholders of Tink AB, the Stockholm headquartered open banking platform, on the intellectual property aspects of its sale to Visa for €1.8 billion.

Alpha Bank's disposal of Alpha Bank Albania, 2021
Alpha Bank on the commercial contracts aspects of its disposal, by way of competitive auction process, of Alpha Bank Albania to OTP Bank.

Klarna Bank's acquisition of Hero Towers, 2021
Klarna Bank, a Swedish fintech company, on the intellectual property aspects of its acquisition of Hero Towers, the operator of the UK's leading “social shopping” e-commerce platform.

Softbank's investment in Zopa, 2021
Softbank Vision Fund II on the intellectual property aspects of its investment as lead investor in the £220 million fundraising by Zopa Group Limited, the UK-based operator of an online lending business that offers a suite of consumer finance solutions.